Skip to content

Study · Animal study (in vivo) · rat · 1982

1 result

[Influence of dermorphin on pancreatic secretion in the rat with gastric fistula].

Baldieri Linari M, Castellacci R, Linari G

Bollettino della Societa italiana di biologia sperimentale1 Dec 1982

PMID7168789 (opens in a new tab)PepBankPUB-07168789
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats with pancreatic fistulae, dermorphin almost completely inhibited 2DG-stimulated pancreatic secretion, irrespective of gastric fistula status.

    In plain wordsIn rats, dermorphin almost completely blocked stimulated pancreatic secretion, both with and without gastric fistulae.

    Peptide
    Dermorphin
    Outcome
    Decrease2DG-stimulated pancreatic secretion
    Study

    ratn: not reported in source

    conscious rats with pancreatic fistulae, with or without gastric fistulae
    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Dermorphin almost completely inhibited the stimulant effect of 2DG, independently by different experimental conditions.
    2 context sentences
    Summary · context
    The influence of the opioid peptide dermorphin on 2DG-stimulated pancreatic secretion of the rat was studied.
    Summary · context
    Experiments were performed in conscious rats with pancreatic fistulae (8 animals), or with pancreatic and gastric fistulae (8 rats) to allow diversion of gastric juice.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.